Stockscreener 앱 받기
113.56
0.36%
0.41
시간 외 거래:
113.58
0.02
+0.02%
전일 마감가:
$113.15
열려 있는:
$113.15
하루 거래량:
7.25M
Relative Volume:
0.67
시가총액:
$280.47B
수익:
$65.51B
순이익/손실:
$8.93B
주가수익비율:
31.96
EPS:
3.5532
순현금흐름:
$14.12B
1주 성능:
+2.35%
1개월 성능:
-6.03%
6개월 성능:
+32.39%
1년 성능:
+43.67%
1일 변동 폭
$112.74
$114.48
1주일 범위
$108.63
$114.62
52주 변동 폭
$73.31
$125.14
머크앤드컴퍼니 Stock (MRK) Company Profile
명칭
Merck Co Inc
전화
908-740-4000
주소
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, AZN, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
113.56 | 279.46B | 65.51B | 8.93B | 14.12B | 3.5532 |
LLY
Lilly Eli Co
|
987.05 | 881.82B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
224.62 | 542.95B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
205.03 | 364.56B | 62.82B | 3.62B | 17.82B | 2.0331 |
AZN
Astrazeneca Plc
|
184.92 | 281.08B | 60.48B | 10.40B | 8.05B | 3.3297 |
NVS
Novartis Ag Adr
|
148.36 | 277.63B | 54.66B | 13.58B | 16.05B | 7.0171 |
머크앤드컴퍼니 Stock (MRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2026-02-20 | 개시 | Barclays | Overweight |
| 2026-02-13 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-01-08 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-10-13 | 재개 | Citigroup | Neutral |
| 2025-09-17 | 다운그레이드 | Berenberg | Buy → Hold |
| 2025-05-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
| 2025-02-18 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-02-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-01-08 | 다운그레이드 | Truist | Buy → Hold |
| 2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 재개 | BofA Securities | Buy |
| 2024-12-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-11 | 다운그레이드 | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-03-11 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2024-01-04 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-27 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Hold |
| 2023-04-13 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-03-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-03-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 개시 | Jefferies | Buy |
| 2023-02-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-10-10 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-09-14 | 업그레이드 | Berenberg | Hold → Buy |
| 2022-07-06 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 재개 | SVB Leerink | Outperform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 개시 | Goldman | Buy |
| 2021-12-16 | 개시 | Daiwa Securities | Neutral |
| 2021-12-13 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-12-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-11-29 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-01 | 업그레이드 | Argus | Hold → Buy |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-20 | 다운그레이드 | Argus | Buy → Hold |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-08-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-06-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-16 | 개시 | SVB Leerink | Outperform |
| 2019-07-03 | 개시 | Mizuho | Buy |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-05-13 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 재확인 | Citigroup | Buy |
| 2018-10-09 | 재개 | Guggenheim | Buy |
| 2018-04-23 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-04-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-03-12 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-02-07 | 재확인 | Morgan Stanley | Equal-Weight |
| 2018-01-16 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
머크앤드컴퍼니 주식(MRK)의 최신 뉴스
Free Cash Flow Investing: Why VFLO Holds Merck Amid Healthcare Headwinds - ETF Database
Analyst Raises Merck (MRK) Price Target by $1 After Beating Q1 Estimates - Insider Monkey
World Investment Advisors Increases Position in Merck & Co., Inc. $MRK - MarketBeat
Indivisible Partners Purchases New Shares in Merck & Co., Inc. $MRK - MarketBeat
Swedbank AB Sells 692,455 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Privium Fund Management B.V. - MarketBeat
Sumitomo Mitsui DS Asset Management Company Ltd Acquires 127,608 Shares of Merck & Co., Inc. $MRK - MarketBeat
Immutrin appoints leading cardiovascular drug development expert Dr. Robert Blaustein as Chief Medical Officer and establishes US subsidiary - GlobeNewswire Inc.
Bokf Na Sells 28,321 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck Completes Acquisition of Terns Pharmaceuticals, Inc. - BioSpace
Merck completes purchase of Terns Pharmaceuticals Inc. - ROI-NJ
Merck completes acquisition of Terns - Breakingthenews.net
Merck completes $53/Share tender, Terns (TERN) merged and delisted - Stock Titan
Merck & Co., Inc. Q1 2026 Quarterly Report – Financial Performance, Business Segments, and SEC Filing Overview - Minichart
Principal Financial Group Inc. Has $535.01 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
QRG Capital Management Inc. Purchases 36,295 Shares of Merck & Co., Inc. $MRK - MarketBeat
Christine Messmer PC Acquires Shares of 17,072 Merck & Co., Inc. $MRK - MarketBeat
Jim Cramer on Merck & Co.: “The Stock’s Starting to Come Back” - Insider Monkey
What Makes Merck & Co. (MRK) an Investment Bet? - Insider Monkey
Truist Financial Corp Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Intact Investment Management Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by M&T Bank Corp - MarketBeat
FSA Advisors Inc. Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Do Wall Street Analysts Like Merck & Co. Stock? - Barchart.com
Wilkins Investment Counsel Inc. Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
PKO Investment Management Joint Stock Co Sells 38,875 Shares of Merck & Co., Inc. $MRK - MarketBeat
CX Institutional Buys 9,768 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck: All The Focus On The Pipeline (NYSE:MRK) - Seeking Alpha
Benjamin Edwards Inc. Trims Position in Merck & Co., Inc. $MRK - MarketBeat
Aurora Private Wealth Inc. Makes New $943,000 Investment in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. Trade Ideas — BSESOF:6MK - TradingView
Merck & Co., Inc. Trade Ideas — BIVA:MRK - TradingView
Strs Ohio Sells 17,995 Shares of Merck & Co., Inc. $MRK - MarketBeat
PFA Pension Forsikringsaktieselskab Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Robertson Stephens Wealth Management LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Horizon Investments LLC - MarketBeat
Sigma Planning Corp Acquires 10,367 Shares of Merck & Co., Inc. $MRK - MarketBeat
MRK Stock Quote Price and Forecast - CNN
Merck & Co., Inc. Q1 Earnings Call Highlights - MarketBeat
Merck (MRK) EVP exercises 1,967 RSUs; 969 shares used for taxes - Stock Titan
Merck (MRK) EVP exercises RSUs, holds over 185K shares via trusts - Stock Titan
Merck (NYSE: MRK) EVP nets more shares after RSU vesting - Stock Titan
Merck (NYSE: MRK) EVP exercises RSUs with tax-withholding share disposition - Stock Titan
Merck (MRK) SVP Smart exercises 1,408 RSUs with 483 shares for tax - Stock Titan
[Form 4] Merck & Co., Inc. Insider Trading Activity - Stock Titan
Merck (NYSE: MRK) EVP exercises 2,951 RSUs, 1,454 shares withheld - Stock Titan
Merck (MRK) HR chief exercises RSUs and withholds 5,858 shares for taxes - Stock Titan
Merck (MRK) CFO Caroline Litchfield exercises RSUs, withholds shares for taxes - Stock Titan
Merck (NYSE: MRK) CEO vests 13,300 RSUs as 6,551 shares withheld for tax - Stock Titan
Merck (NYSE: MRK) EVP nets shares after RSU vest and tax withholding - Stock Titan
머크앤드컴퍼니 (MRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.97%
0.52%
자본화:
|
볼륨(24시간):